Channel - Research to Practice Telehealth Lectures
2/12/2020 2:40:18 PM

Channel Videos

A New Era: Immunotherapy in Non-Small Cell Lung Cancer - C. Pecot - 2018221
This presentation describes the rationale behind using immunotherapy in lung cancer, the current standard of care use of immunotherapy, and future directions.
Chad Pecot MD
2/21/2018 4:30:00 PM
View

Acute Myeloid Leukemia (AML): Finally Making Progress? - J. Zeidner - 20180523
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development.
UNCCN Mediasite Presenter
5/23/2018 3:30:00 PM
View

Advances in Melanoma Cancer Treatment - F. Collichio - 20171115
This presentation reviews melanoma from diagnosis through treatment using a case study approach. The speaker reviews AJCC staging guidelines, basic biologic principles, various treatment options, and side effects of treatment. The content includes what’s new for melanoma management and thoughts on future research directions. Learning Outcomes: • Review the ABCDEs for melanoma. • Know the standard of care for each stage of disease including the new treatments for stage III. • Know how to recognize the side effects of therapy. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
11/15/2017 4:30:00 PM
View

Advances in Metastatic Prostate Cancer - M. Milowsky - 20160622
This lecture discusses some of the advancements in Metastatic Prostate Cancer such as the use of newer hormonal agents and Docetaxel chemotherapy against castration-sensitive metastatic prostate cancer. Learning Outcomes: • Discuss newer hormonal agents in the management of castration-resistant metastatic prostate cancer. • Examine a new role for Docetaxel chemotherapy in the management of castration-sensitive metastatic prostate cancer. • Compare other novel agents in the management of advanced prostate cancer. This lecture was presented as a part of the Medical and Surgical Oncology Series.
Matthew Milowsky MD
6/22/2016 3:30:00 PM
View

An Overview of Melanoma, with an emphasis on the systemic treatments - F. Collichio - 20141022
This lecture will discuss the causes and prevalance of malignant melanoma and talk about the treatment methods for the different stages. Learning Outcomes: 1. Recognize melanoma skin cancer. 2. Describe broad treatment by stage. 3. Know the different categories of systemic treatment. 4. Manage the side effects of therapy. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
10/22/2014 3:55:00 PM
View

Brain Metastases Program - C. Anders and T. Zagar - 20140122
Carey Anders MD
1/22/2014 4:55:00 PM
View

Cancer Pain Management - D. L. James - 20160525
This lecture will discuss the epidemiology and pathophysiology of cancer pain and focus on the principles of multimodal analgesia. Dr. James will also elucidate novel therapies in cancer pain management. Learning Outcomes: • Discuss epidemiology and pathophysiology of cancer pain. • Explain principles of multimodal analgesia. • Elucidate novel therapies in cancer pain management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Dominika L James MD
5/25/2016 3:30:00 PM
View

Choosing Therapy for Melanoma and Managing Side Effects - F. Collichio - 20160323
In this lecture, Dr. Frances Collichio looks at how clinical trials relate to melanoma research from a high-level perspective. She will also discuss the serious side effects of immunotherapy, when it is appropriate to recommend and how to mitigate the side effects. Learning Outcomes: • Examine the big picture of clinical trials and how they relate to melanoma research. • Identify when it is appropriate to recommend immunotherapy. • Evaluate the serious side effects of immunotherapy and their management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
3/23/2016 3:30:00 PM
View

Crisis:The Rising Cost of Cancer Care in the United States - T. Khan and B. Muluneh - 20140625
This lecture will discuss the current crisis of rising cancer care costs driving some patients to near bankruptcy. Learning Outcomes: 1. Discuss the current state of increased health care costs in the United States 2. Discuss the impact of increased health care costs on oral chemotherapy non-adherence 3. Propose potential solutions for addressing the financial challenges in cancer care This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Tippu Khan PharmD
6/25/2014 3:55:00 PM
View

Current Treatment Paradigms for Pancreatic Cancer - H. Sanoff - 20140924
The speaker will begin with the basics of pancreatic cancer and symptoms in its early stages. The discussion will continue to the treatment paradigms by advancement of the disease. The lecture will conclude by highlighting new advancements in the treatment of pancreatic cancer. Learning Outcomes: 1. Learn the basics of Pancreatic Cancer 2. Explain treatment paradigms by extent of disease 3. Identify new treatment strategies for Pancreatic Cancer This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Hanna Sanoff MD
9/24/2014 3:55:00 PM
View

Enhancing the Patient Voice in Clinical Care through Patient-Reported Data - B. Reeve - 20151118
A patient's involvement in their own care is critical to their survivorship by improved acceptance of their treatment, greater likelihood of adhering to treatment, and better managing their symptoms. Learn how to improve doctor-patient communication, decision-making, and ultimately health outcomes. Learning Objectives: • Identify the types of patient-reported data that may be relevant for improving quality of care. • Describe the strengths and challenges for integrating patient-reported data into clinical practice settings. • Discuss the role of Health IT to collect, store, and report patient-reported data. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
PhD Bryce Reeve
11/18/2015 4:15:00 PM
View

Fertility Preservation in Male Oncology Patients - M. Coward - 20150325
This lecture discusses the different scenarios of fertility preservation issues for male oncology patients depending on what stage in life the patient is in. Learning Outcomes: 1. Understand the concept of oncofertility and its importance for young cancer patients 2. Describe how cancer and cancer treatments affect male fertility, and understand all of the methods of fertility preservation, beyond sperm banking, for male patients 3. Know when and who to refer for fertility preservation and how to counsel patients about their options This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Matthew Coward MD
3/25/2015 3:55:00 PM
View

GU Cancers: Best of ASCO - M. Milowsky - 20180425
UNCCN Mediasite Presenter
4/25/2018 3:30:00 PM
View

Immunological Mechanisms in Pancreatic Cancer - Y. P. Gupta - 20190327
This lecture will review the current understanding of the role of immune system in pancreatic cancer and provide insight into development of the latest immune-based therapies aimed at treating patients with pancreatic cancer.
UNCCN Mediasite Presenter
3/27/2019 3:30:00 PM
View

Impact of Patient Reported Outcomes on Patient Care - E. Basch - 20170524
This lecture will provide an overview of current news and advances in patient-reported outcomes research. Patient-reported outcomes includes assessment of patient symptoms, adverse events, functional status, and overall quality of life. The presentation will also discuss ways patient-reported outcomes can be used to assess and improve patient care specific to oncology patients. Lecture Objectives: -Explain the value of patient symptom reporting. -Describe electronic communication systems for symptom management. -Recognize national efforts to develop PRO systems in EHRs. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Ethan Basch MD
5/24/2017 3:30:00 PM
View

Improving Outcomes In Radical Cystectomy - R. S. Pruthi - 20190424
The lecture will evaluate the recent improvements in patients undergoing radical cystectomy for bladder cancer (including peri-operative chemotherapy and robotic surgery), and will describe some of the obstacles to providing optimal care that still exist.
Raj S. Pruthi, MD
4/24/2019 3:30:00 PM
View

Infections in Cancer Patients - D. V. Duin - 20161116
This lecture discusses infections in cancer patients, including practice guidelines for management of neutropenia and hematopoietic stem cell transplantation. This presentation also discusses antibiotic resistance, antimicrobial stewardship, and infection control relevant to patients with cancer. Learning Outcomes: • Describe the epidemiology of infections in patients with cancer. • Discuss risk factors for infection in patients with cancer. • Identify methods of decreasing risk of infection in patients with cancer. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
David van Duin MD, PhD
11/16/2016 4:30:00 PM
View

Late Effects of Childhood Cancer - J. Blatt - 20150722
This lecture will discuss the latent systemic effects for childhood cancer survivors. Dr. Julie Blatt explains how every organ is essentially at risk dependent upon type of treatment, age, and gender. Learning Outcomes: • to recognize the high cure rate in children with cancer • to describe the spectrum of possible late effects • to explain the role of the PCP and dedicated survivorship clinic in monitoring late effects This lecture was presented as a part of the Medical and Surgical Oncology Series.
UNCCN Mediasite Presenter
7/22/2015 3:30:00 PM
View

Lung Cancer Screening - M. P. Rivera - 20152204
This lecture will discuss balancing the risk and benefits of lung cancer screening in asymptomatic, high-risk individuals. Learning Outcomes: 1. Understand the criteria for screening for lung cancer 2. Review the risks and benefits of screening 3. Discuss role of prediction models in screening This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
M. Patricia Rivera MD
4/22/2015 3:40:00 PM
View

Managing Lung Cancer Heterogeneity - J. Akulian - 20180124
The most common lung cancers are known to have diverse pathological features and recent research has further identified distinct diseases with genetic and cellular heterogeneity. This lecture will provide strategies for managing this heterogeneity during clinical evaluation and treatment of patients. Lecture Objectives: Define lung cancer heterogeneity. Discuss lung cancer heterogeneity. Identify treatment decisions based on a patient's lung cancer heterogeneity.
UNCCN Mediasite Presenter
1/24/2018 4:30:00 PM
View

Meeting the Unique Needs of Pediatric Oncology Patient - T. Alexander - 20180328
Every year, an estimated 250,000+ new cases of cancer affect children under the age of 20 worldwide. This presentation provides an overview of common pediatric oncology diseases, the general outcomes, and recent treatment advances.
John Alexander, MD,MPH
3/28/2018 3:30:00 PM
View

Metastatic Breast Cancer - C. Dees - 20171213
This presentation discusses management of metastatic breast cancer. The presenter will provide a review of current systemic therapy options and will review advances in management strategies, including ongoing studies, for metastatic breast cancer. Learning Outcomes: • Understand systemic therapy options for HR+ Her2- metastatic breast cancer. • Understand systemic therapy options for Her2+ metastatic breast cancer. • Understand systemic therapy options for triple negative metastatic breast cancer. This presentation is presented as part of Medical and Surgical Oncology Lecture series.
Claire Dees MD, MSc
12/13/2017 4:30:00 PM
View

Metastatic Breast Cancer - L. Carey - 20190626
Of women diagnosed with early-stage breast cancer, almost 30% will develop metastatic disease. Genomic testing of metastatic breast cancer will help us determine which forms of breast cancer are likely to return in other parts of the body.
Lisa Carey MD
6/26/2019 3:30:00 PM
View

Neoadjuvant Approaches to Breast Cancer: When, Why and How - L. Carey and D. Ollila - 20141119
This lecture will discuss Neoadjuvant therapy and its advantages in minimizing surgery. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Lisa Carey MD
11/19/2014 4:55:00 PM
View

New Options for Immunotherapy: Where We Are and Where We’re Going - B. Vincent - 20170726
Benjamin Vincent MD
7/26/2017 3:30:00 PM
View

Non-Muscle Invasive Bladder Cancer: Diagnostic and Treatment Strategies - A. Smith - 20150527
This lecture discusses the unmet need for new treatment options associated with fewer complications, better patient compliance, and increased prevention of recurrence in non-muscle invasive bladder cancer. Objectives: 1. Explain risk stratification of non-muscle invasive bladder cancer (NMIBC) 2. Discuss about urinary markers and cystoscopic enhancement techniques in diagnosis and management of NMIBC 3. Describe the treatment guidelines involved with NMIBC, including intravesical therapies, surgical procedures, and surveillance. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
5/27/2015 3:30:00 PM
View

Obesity in Gynecologic Oncology: A Growing Epidemic - P. Gehrig - 20160224
The lecture will discuss the impact that obesity has on the development of gynecologic malignancies and the outcomes of those malignancies. Medical options for treating obesity will also be talked about as a preventative measure. • Discuss the obesity epidemic in the United States. • Assess the impact of obesity on the development of, and outcomes from, gynecologic malignancies. • Compare and contrast the medical options for treating obesity as a preventative measure. This lecture was presented as a part of the Medical and Surgical Oncology Series.
Paola Gehrig MD
2/24/2016 4:30:00 PM
View

Optimizing Care for the Older Cancer Patient - T. Jolly and H. Muss - 20140226
Trevor Jolly MBBS
2/26/2014 4:55:00 PM
View

Pediatric Oncology: Past, Present and Future Directions - S. Gold - 20151028
Dr. Stuart Gold, Chief of Staff of the UNC Pediatric Hematology/Oncology Division will discuss the important principles to understanding childhood cancer including the different types of pediatric cancer, pediatric oncology cooperative groups, ALL advances and the significant role that cytogenetics plays in ALL. Learning Outcomes: • Understand childhood cancer cooperative groups. • Understand childhood acute lymphoblastic leukemia and its treatment. • Understand where pediatric oncology has been and what the future may bring. This lecture was presented as a part of the Medical and Surgical Oncology Series
UNCCN Mediasite Presenter
10/28/2015 3:30:00 PM
View

Pharmacogenomics and Individual Therapy Research - F. Innocenti - 20161026
This lecture provides information on the advances in pharmacogenomic screening and its implication to clinical research and practice. The presentation reviews the use of genomics in clinical trials, determining the clinical utility of a genetic test, use of somatic DNA screening for drug therapy outside of oncology, and precision dosing of medications within oncology. Learning Outcomes: -Describe advances in screening for somatic mutations in tumor DNA. -Identify implications of somatic DNA screens for drug therapy outside of oncology. -Discuss precision dosing of cancer drugs. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Federico Innocenti MD, PhD
10/26/2016 3:30:00 PM
View

Promising New Treatment Options for Rectal Cancer - K. Stitzenberg - 20170322
The information presented in this lecture is designed to assist the health care provider in understanding treatments for rectal cancer. This program will review the standard of care for rectal cancer based on staging and discuss emerging and investigational treatment paradigms. Lecture Objectives: -Discuss emerging treatment paradigms for rectal cancer with understanding of what is standard of care and what is still investigational. -Discuss new surgical approaches to rectal cancer with understanding of what is standard of care and what is still investigational. -Discuss the potential risks and benefits of emerging treatment paradigms. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Karyn Stitzenberg MD, MPH, FACS
3/22/2017 3:30:00 PM
View

Recent Advances in Radiation Oncology - A. Wang and M. Eblan - 20150624
This lecture discusses radiation therapy as a key component in the curative regimen for many cancers. The speaker will review new technologies in radiation oncology including Arc therapy, image guidance, and radiosurgery. Learning Outcomes: • Explain current advances in radiation oncology • Describe recent practice changes in radiotherapy for different types of cancers • Identify future developments in radiation oncology, including immunotherapy and nanomedicine This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series
UNCCN Mediasite Presenter
6/24/2015 3:30:00 PM
View

Renal Cell Carcinoma: Past, Present, and Future - T. Rose - 20170823
Information presented in this presentation is designed to increase knowledge about renal cell carcinoma (RCC). Information focuses on risk factors associated with RCC, the standard treatments for both localized and metastatic disease, and the future for RCC treatment. Learning Outcomes: • State the risk factors for kidney cancer, including the genetic syndromes associated with renal cell carcinoma. • Discuss the current status of adjuvant treatment for high-risk localized kidney cancer. • State the standard first- and second-line systemic therapies for metastatic kidney cancer. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Tracy Rose MD,MPH
8/23/2017 3:30:00 PM
View

Sickle Cell Disease: An Overview and Updates - K. Ataga - 20170125
The CDC estimates that Sickle Cell Disease affects approximately 100,000 Americans. This lecture will provide an overview of this group of inherited red blood cell disorders along with updates on current research in the field. Lecture Objectives: -Identify the various sickle cell syndromes. -Describe the pathophysiology of sickle cell disease. -Implement the NHLBI evidence-based guidelines for management of sickle cell disease. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Kenneth Ataga MBBS
1/25/2017 4:30:00 PM
View

Special Considerations for Patients and Mental Illness and Cancer - D. Rosenstein - 20160727
This lecture provides an overview of the critical role behavior has in oncology and discusses how to assess and manage psychiatric symptoms with a focus on suicide in cancer patients. Learning Outcomes: • Identify common challenges faced by psychiatric patients who are treated for cancer. • Describe important drug-interactions with psychotropic medications. • Employ sensitivity to previously traumatized patients. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Donald Rosenstein MD
7/27/2016 3:30:00 PM
View

The Difficult Patient - J. Johnson - 20150304
This talk will highlight some of the most dreaded patients we see in healthcare, the"Difficult Patient." This patient typically involves ones with substance use disorders or those with personality traits that make them angry, irritable, demanding, condescending, or threatening. This talk will outline ways to think about "difficult patients", providing examples as well as a basic psychological understanding of why certain patients act certain ways. Finally, it will provide behavioral and medical ways for managing difficult patients so that staff feels more comfortable managing these types of people when they are in their clinic or hospital. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Justin Johnson MD
3/4/2015 4:55:00 PM
View

The Impact of Centralization of Major Cancer Surgery - K. Stitzenberg - 20140723
This lecture discusses the advantages of centralizing surgeries in cases of major cancers such as Esophageal and Pancreatic cancers. Learning Outcomes: * To evaluate temporal trends in the mortality and concentration of high-risk oncological procedures. * To assess the risk/benefit ratio for centralization of major cancers such as Esophageal and Pancreatic cancers. This lecture was presented as a Medical Surgical Oncology Lecture Series.
Karyn Stitzenberg MD, MPH
7/23/2014 3:55:00 PM
View

The Odyssey of Cancer Pain in Women - D. Zolnoun - 20140326
Objectives: 1. Develop a framework for inquiry into urogenital symptoms 2. Provide symptoms-based palliative treatment regimen for patients with urogenital symptoms undergoing chemo/radiation therapy
Denniz Zolnoun MD, MPH
3/26/2014 3:55:00 PM
View

The Problem of Suicide in the Oncology Setting - D. Rosenstein - 20140528
This lecture will discuss the topic of suicide within the cancer patient population and how while its often difficult to predict, clinicians can assess risk and screen for suicidal ideation and respond accordingly. Learning Outcomes: * Overview of risk and protective factors * Recognize that the patient at-risk for suicide is relevant to all clinicians. * Learn the different components that go into screening for Suicide This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Donald Rosenstein MD
5/28/2014 3:55:00 PM
View

The Role of Radiation Therapy in Advanced and Metastatic Disease - K. Pearlstein - 20171025
This presentation discusses common palliative radiation treatments, techniques, and toxicities. The content reviews current guidelines for the use of radiation in advanced and metastatic disease as well as oligometastatic disease. Learning Outcomes: • Identify symptoms that can be effectively treated with palliative radiotherapy and describe common palliative treatment approaches. • Recognize the role of radiation in providing local control for locally advanced and oligometastatic disease. • Recognize acute and late toxicities of radiotherapy for different treatment sites. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Kevin Pearlstein MD
10/25/2017 3:30:00 PM
View

Treatment of Relapsed and Refractory Multiple Myeloma - B. Reeves - 20170628
Purpose: This presentation discusses current strategies for managing relapsed and refractory multiple myeloma. Update are provided on appropriate chemotherapy regimens for relapsed and refractory multiple myeloma, including new options of treatment for this disease. The presentation also reviews factors influencing treatment, including when treatment should be initiated and discontinued. Learning Outcomes: -Determine when to start treatment in the context of relapsed multiple myeloma. -Identify appropriate chemotherapy regimens for relapsed multiple myeloma. -Understand new drugs in clinical trial for relapsed and refractory multiple myeloma. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Brandi Reeves MD
6/28/2017 3:30:00 PM
View

Tumor Treating Fields for Glioblastoma - Simon Khagi - 20180926
Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift in the field of neuro-oncology. We will focus our discussion on the biological underpinnings of this device and clinical data supporting its use.
Simon Khagi, MD
9/26/2018 3:30:00 PM
View

Understanding and Treating Anxiety & Depression in Patients and Families with Advanced Cancer - E. Park - 20181128
Dr. Park will review the presenting symptoms, diagnostic approach, and initial management of anxiety and depressive disorders in patients and families affected by cancer. She will additionally review challenges specific to the management of patients with advanced or terminal cancer. For continuing education credits for this and other lectures, please visit our Learning Portal at learn.unc.org.
Leeza Park MD
11/28/2018 4:30:00 PM
View

Update in Breast Cancer Imaging & Molecular Classification - C. Kuzmiak - 20150923
This lecture will discuss and compare the various methods of breast imaging for screening and diagnostic assessment. The speaker will also explain the image finding characteristic of each major molecular subtype of breast cancer and their targeted therapies. Learning Outcomes: • Explain the benefits & limitations of 2D & 3D mammography, whole breast ultrasound and magnetic resonance imaging - individually and when used in combination. • Compare & contrast the imaging findings characteristic of each major molecular subtype of breast cancer. • Recognize the importance of the molecular classification of breast cancer with targeted therapies and overall survival outcome. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
9/23/2015 3:30:00 PM
View

Update on CAR T Therapy - N. Grover - 20181219
This lecture will give an overview of CAR-T cells, discuss recent clinical trial results and FDA approvals as well as current clinical applications. This lecture will also cover the management of the unique toxicities of CAR-T therapy. Finally, this lecture will discuss some of the ongoing trial of CAR-T therapy as well as future directions of the field. For continuing education credits for this and other lectures, please visit our Learning Portal at learn.unc.org.
UNCCN Mediasite Presenter
12/19/2018 4:30:00 PM
View

Updates in Breast Cancer Epidemiology and Pathogenesis - M. Troester - 20160427
This lecture will discuss the latest research in the scope of epidemiology and pathology to gain a better understanding of both the survivorship and causes of breast cancer. Dr. Troester will focus on mortality disparities in races and the research challenges for resolving these disparities. Learning Outcomes: • Describe the subtypes of breast cancer and how they are identified with tissue biomarkers. • Illustrate differences in risk factor and survivorship profiles for breast cancer subtypes. • Describe racial disparities in incidence and mortality from cancer and highlight remaining research challenges for understanding and resolving disparities. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Melissa Troester PhD
4/27/2016 3:30:00 PM
View

Updates in Gynecologic Oncology - W. Brewster - 20150826
This lecture will discuss the prevalence of gynecological cancers in the US and the role that obesity plays in these numbers. The discussion will also review the surgical, chemotherapy, and biological options for epithelial ovarian cancer and recurrent endometrial cancer. Learning Outcomes: • Discuss surgical therapies for gynecologic malignancies • Describe chemotherapy and radiation options for gynecologic malignancies • Identify new developments in genetics This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
8/26/2015 3:30:00 PM
View

Updates in Interventional Pulmonology - J. Akulian - 20140827
This lecture will discuss what Interventional Pulmonology is, including the subtexts of advanced diagnostic bronchoscopy and therapeutic bronchoscopy. Learning Outcomes: * What is Interventional Pulmonology? * Discuss the symptoms of Central Airway Obstruction * Discuss the advantages of diagnostic bronchoscopy. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Jason Akulian MD, MPH
8/27/2014 3:55:00 PM
View

Updates in Lung Cancer from ASCO 2016 - J. Weiss - 20160824
This lecture provides a review of 2016 updates from the American Society of Clinical Oncology and includes recognizing new treatment plans for patients with lung cancer, how intensive follow-up can improve the quality of life and survival for thoracic oncology patients, and using American Joint Committee on Cancer (AJCC) in treatment planning. Learning Outcomes: • Recognize new treatments that are available for metastatic lung cancer, localized lung cancer, and small cell lung cancer. • Describe the role that intensive follow-up can play in improving quality of life and survival for thoracic oncology patients. • Discuss use of American Joint Committee on Cancer (AJCC) in treatment planning to ensure appropriate prognostic indicators and evidence-based national guidelines are used when developing treatment plans for thoracic oncology patients. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Jared Weiss MD
8/24/2016 3:30:00 PM
View

Using Biomarkers to Plan Adjuvant Therepy in Breast Cancer - L. A. Carey - 20180627
It is difficult to determine whether a primary therapy has suppressed or killed a cancer. Adjuvant therapy can further improve the chances that the cancer will not return. In this presentation Dr. Cary will discuss which adjuvant therapy options are available for breast cancer patients as well as some of the recent developments in adjuvant therapy.
UNCCN Mediasite Presenter
6/27/2018 3:30:00 PM
View

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Mediasite
Sonic Foundry